Page last updated: 2024-10-23

azathioprine and Cervical Tuberculous Lymphadenitis

azathioprine has been researched along with Cervical Tuberculous Lymphadenitis in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research Excerpts

ExcerptRelevanceReference
"Two months later, he developed axillary lymph node tuberculosis caused by Mycobacterium tuberculosis."1.31Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation. ( Budde, K; Neumayer, HH; Schötschel, R; Waiser, J, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Winter, JH1
Legge, JS1
Waiser, J1
Schötschel, R1
Budde, K1
Neumayer, HH1

Other Studies

2 other studies available for azathioprine and Cervical Tuberculous Lymphadenitis

ArticleYear
Acute tuberculous lymphadenopathy in an immunosuppressed patient.
    British medical journal (Clinical research ed.), 1983, Jan-01, Volume: 286, Issue:6358

    Topics: Acute Disease; Azathioprine; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Tuberculosi

1983
Reactivation of tuberculosis after conversion from azathioprine to mycophenolate mofetil 16 years after renal transplantation.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 35, Issue:3

    Topics: Azathioprine; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycopheno

2000